ORPHEUS BIOSCIENCE
Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases. The company core technology the Pantid is designed to specifically neutralize the pathological component of patient antibody responses and destroy destructive immune cells, without affecting the patient's immune system functionality. This patent includes a novel mechanism of action, targeting autoreactive B cells that specifically react to patient-endogenous proteins, as well as several novel mechanisms for their elimination. Orpheus Bioscience was founded in 2016 and is based in Manassas, Virginia, USA.
ORPHEUS BIOSCIENCE
Industry:
Biotechnology Health Care Life Science
Founded:
2016-01-01
Address:
Manassas, Virginia, United States
Country:
United States
Website Url:
http://www.orpheusbioscience.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome ReCAPTCHA JsDelivr AJAX Libraries API Contact Form 7
Similar Organizations
Cell Activation
Cell Activation is a privately held company that develops tests that identify inappropriate and damaging cell activation.
Celltech Chiroscience
Celltech Chiroscience is a british-based biotech company, founded by Christopher Evans.
Flightpath Biosciences
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Marligen Biosciences
Marligen Biosciences is a privately held seller of DNA and RNA purification kits and multiplex assays for genotyping.
Razor Genomics
Razor Genomics is a life science company that researches and develops novel tests for the diagnosis of lung cancer located in Brisbane.
Sophion Bioscience
Sophion Bioscience offers automated patch clamp systems that can be used in laboratories for drug discoveries.
UCP Biosciences
UCP Biosciences supplies test cups, dip cards, saliva tests, cardiac makers, test strips, and u-readers for various infectious diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
ZUS Biotech
ZUS Biotech is a Croatia-based Biotech startup that helps bees to better immunity, and higher honey.
Official Site Inspections
http://www.orpheusbioscience.com
- Host name: 108-167-165-248.unifiedlayer.com
- IP address: 108.167.165.248
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Orpheus Bioscience"
About Us - Orpheus BioScience
About Us Mission Statement. Orpheus is focused on providing a treatment for retinopathy of prematurity (ROP), a potentially blinding affliction that occurs in premature neonates.See details»
Orpheus Bioscience - Crunchbase Company Profile
Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases. The company core technology the …See details»
Orpheus Bioscience Company Profile | Management and
Www.orpheusbioscience.com . Orpheus Bioscience Profile and History. Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases. The …See details»
Orpheus Bioscience, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 9, 2023 Last update 01 Jun 2023. Orpheus Bioscience, Inc. Private Company |See details»
Orpheus Bioscience - Overview, News & Similar companies
Who is Orpheus Bioscience. Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases. The company core technology the Pantid …See details»
Orpheus Bioscience - Products, Competitors, Financials, Employees ...
Headquarters Location. 9385 Discovery Blvd. Suite 115. Manassas, Virginia, 20109, United States. 212-692-6758See details»
Contact Us - Orpheus BioScience
Your Name (required) Your Email (required) Subject. [recaptcha] Copyright © Orpheus BioScience, LLC 2018 - All Rights ReservedSee details»
Orpheus BioScience - VentureRadar
Website: http://orpheusbioscience.com/ Develops novel treatments for autoimmune diseases using PantId®, a protein-based therapeutic designed to eliminate ...See details»
Nextsource | Company Profile | Orpheus Bioscience
Explore the company profile of Orpheus Bioscience (orpheusbioscience.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Orpheus Bioscience - Tech Stack, Apps, Patents & Trademarks
Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases.See details»
Orpheus (Biotechnology) - PitchBook
Orpheus (Biotechnology) General Information Description. Operator of a biotechnology company intended to develop novel therapeutics for autoimmune disorders. The company performs …See details»
The latest R&D info about Orpheus Bioscience, Inc.: pipelines, …
May 4, 2023 Find drug R&D information for Orpheus Bioscience, Inc.. including drug pipeline ... Orpheus Bioscience, Inc. has a total of 0 Literature ...See details»
Science - Orpheus BioScience
Figure 2: PR1P reduces the loss of blood vessels in phase I of the OIR model and prevents pathological neovascularization in phase II. Zones afflicted by vaso-obliteration (phase I) or …See details»
OBIO - LinkedIn
OBIO | 12,177 followers on LinkedIn. Addressing the needs of the next generation of companies developing innovative human health products. | Founded in 2009, OBIO® is a not-for-profit, …See details»
Pipeline - Orpheus BioScience
The Orpheus Solution. To redress the risk of blindness in premature neonates, Orpheus proposes the use of a novel peptide therapeutic, PR1P, which can be administered prophylactically to …See details»
For-profit plasma dangerous to Canadian blood supply chain, …
Jul 19, 2022 There is no place for private, for-profit companies in the Canadian blood supply chain, President JP Hornick writes in a letter to the CEO of Canadian Blood Services, co …See details»
Revolutionizing Drug Discovery: The Impact of Orpheus in Drug ...
Jan 19, 2024 IDRI (Infectious Disease Research Institute), based in Seattle, is a non-profit biotech organization dedicated to comprehensively addressing infectious diseases. Merging …See details»
News - Orpheus BioScience
News. Orpheus has licensced the PR1P technology from Boston Children’s Hospital, where it was originally develped and characterized, to facilitate the preclinical and clinical development of …See details»
The PantId - Orpheus BioScience
Tolerogenesis Some of our PantIds® include native negative immune signaling molecules, called negative checkpoint receptors or ligands. Preliminary research indicates that these PantIds® …See details»